Sign up to save your podcasts
Or
Share Recent FDA Approvals in Leukemia and Lymphoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recent FDA Approvals in Leukemia and Lymphoma
This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AMLThis week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
View all episodes
By BroadcastMed
4.5
1515 ratings
This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:This week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AMLThis week, we'll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma